Merck Signs $2.13 Billion Deal for SciBrunch Cancer Drug Targeting KRAS G12D
Merck said it will pay up to $2.13 billion under...
Merck said it will pay up to $2.13 billion under...
The landscape of cancer treatment is undergoing a transformative shift...